Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines

被引：73

作者：

Chen, CH

Wang, TL

Hung, CF

Pardoll, DM

Wu, TC

机构：

[1] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA

[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan

[3] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA

[4] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21287 USA

[5] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21287 USA

来源：

VACCINE | 2000年 / 18卷 / 19期

关键词：

HPV-16; DNA vaccine; vaccinia;

D O I：

10.1016/S0264-410X(99)00528-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We have previously linked the sorting signals of the lysosome-associated membrane protein-1 (LAMP-1) to HPV-16 E7 antigen, creating a chimera, Sig/E7/LAMP-1. We found that both Sig/E7/LAMP-1-containing recombinant vaccinia virus (Vac-Sig/E7/LAMP-1) and Sig/E7/LAMP-1 DNA can generate strong antitumor immunity. To determine whether combination of Sig/E7/LAMP-1 DNA and Vac-Sig/E7/LAMP-1 can further enhance immune responses, sequential vaccination with Sig/E7/ LAMP-1 DNA and Vac-Sig/E7/LAMP-1 was given. We found that priming with Sig/E7/LAMP-1 DNA and boosting with Vac-Sig/E7/LAMP-1 generated the strongest E7-specific CD8+ T cell responses. Our results encourage the use of the DNA prime/vaccinia booster regimen in future clinical trials. (C) 2000 Elsevier Science Ltd. All rights reserved.

引用

页码：2015 / 2022

页数：8

共 27 条

[1] Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity
Belyakov, IM
Moss, B
Strober, W
Berzofsky, JA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4512 - 4517
[2] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
BOSCH, FX
MANOS, MM
MUNOZ, N
SHERMAN, M
JANSEN, AM
PETO, J
SCHIFFMAN, MH
MORENO, V
KURMAN, R
SHAH, KV
ALIHONOU, E
BAYO, S
MOKHTAR, HC
CHICAREON, S
DAUDT, A
DELOSRIOS, E
GHADIRIAN, P
KITINYA, JN
KOULIBALY, M
NGELANGEL, C
TINTORE, LMP
RIOSDALENZ, JL
SARJADI
SCHNEIDER, A
TAFUR, L
TEYSSIE, AR
ROLON, PA
TORROELLA, M
TAPIA, AV
WABINGA, HR
ZATONSKI, W
SYLLA, B
VIZCAINO, P
MAGNIN, D
KALDOR, J
GREER, C
WHEELER, C
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
[3] CHEN CH, IN PRESS GENE THERAP
[4] VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS
FELTKAMP, MCW
SMITS, HL
VIERBOOM, MPM
MINNAAR, RP
DEJONGH, BM
DRIJFHOUT, JW
TERSCHEGGET, J
MELIEF, CJM
KAST, WM
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2242 - 2249
[5] Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques
Fuller, DH
Corb, MM
Barnett, S
Steimer, K
Haynes, JR
[J]. VACCINE, 1997, 15 (08) : 924 - 926
[6] Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; Comparisons and combinations
Gilbert, SC
Schneider, J
Plebanski, M
Hannan, CM
Blanchard, TJ
Smith, GL
Hill, AVS
[J]. BIOLOGICAL CHEMISTRY, 1999, 380 (03) : 299 - 303
[7] Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants
Gonzalo, RM
Rodríguez, D
García-Sastre, A
Rodríguez, JR
Palese, P
Esteban, M
[J]. VACCINE, 1999, 17 (7-8) : 887 - 892
[8] Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
Hanke, T
Samuel, RV
Blanchard, TJ
Neumann, VC
Allen, TM
Boyson, JE
Sharpe, SA
Cook, N
Smith, GL
Watkins, DI
Cranage, MP
McMichael, AJ
[J]. JOURNAL OF VIROLOGY, 1999, 73 (09) : 7524 - 7532
[9] Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime
Hanke, T
Neumann, VC
Blanchard, TJ
Sweeney, P
Hill, AVS
Smith, GL
McMichael, A
[J]. VACCINE, 1999, 17 (06) : 589 - 596
[10] Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime MVA boost vaccination regime
Hanke, T
Blanchard, TJ
Schneider, J
Hannan, CM
Becker, M
Gilbert, SC
Hill, AVS
Smith, GL
McMichael, A
[J]. VACCINE, 1998, 16 (05) : 439 - 445

← 1 2 3 →